close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

94.95 -0.46 (-0.48%)
Official Closing Price Updated: 7:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
Elective procedures are recovering slowly as Covid cases decline. Will they ever boom? 
Via Investor's Business Daily
Hopeful Golden Cross Forms On Boston Scientific's Chart
If history is any guide, there may be good fortune ahead for shares of Boston Scientific (NYSE:BSX). A so-called "golden cross" has formed on its chart and, not surprisingly,... 
Via Benzinga
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96. 
Via Investor's Business Daily
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Is Boston Scientific Stock Trading Lower Premarket Today?
Boston Scientific Corp (NYSE: BSX) generated  
Via Benzinga
Executives Sell More Than $210M Of 5 Stocks
Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades.... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Boston Scientific
Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Boston Scientific Tumbles On Lackluster Guidance Despite Fourth-Quarter Beat
The company topped expectations in the fourth quarter, but guidance disappointed. 
Via Investor's Business Daily
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Boston Scientific: Q4 Earnings Insights
  Boston Scientific (NYSE:BSX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 2, 2022
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion. 
Via Benzinga
What Does Boston Scientific's Debt Look Like?
Over the past three months, shares of Boston Scientific (NYSE:BSX) increased by 0.05%. Before we understand the importance of debt, let us look at how much debt Boston... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What Does Boston Scientific's Debt Look Like?
Shares of Boston Scientific (NYSE:BSX) decreased by 6.16% in the past three months. Before having a look at the importance of debt, let us look at how much debt Boston... 
Via Benzinga
2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. 
Via Talk Markets
Ominous Death Cross Forms On Boston Scientific's Chart
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
Boston Scientific Corp (BSX) Q3 2021 Earnings Call Transcript
BSX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales... 
Via Benzinga
Recap: Boston Scientific Q3 Earnings
Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Boston Scientific's Eluvia Drug-Eluting Vascular Stent Tops Bare Metal Stents
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular InterVentional... 
Via Benzinga
Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Baylis Medical Company Inc for an upfront payment of $1.75 billion. The acquisition will... 
Via Benzinga
Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary Embolism
Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional Advances (VIVA) meeting. ... 
Via Benzinga
FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants
The FDA informed health care providers of the potential for differences in procedural outcomes between women and men undergoing implant of a left atrial appendage... 
Via Benzinga
Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
Via FinancialNewsMedia
Boston Scientific Acquires Provider Of Thrombectomy Platform In Over $300M Deal
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Devoro Medical Inc for over 300 million. Boston Scientific has been a strategic investor in... 
Via Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
Via Benzinga
Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads
Boston Scientific Corporation (NYSE: BSX) announced that the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) met both primary... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today